Dentsply Sirona (XRAY)
(Delayed Data from NSDQ)
$30.57 USD
+0.22 (0.72%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $30.63 +0.06 (0.20%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
XRAY 30.57 +0.22(0.72%)
Will XRAY be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for XRAY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for XRAY
Why Dentsply International (XRAY) is a Top Value Stock for the Long-Term
Why Dentsply International (XRAY) is a Top Value Stock for the Long-Term
XRAY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Dentsply International (XRAY) is a Strong Value Stock
Here's Why Dentsply International (XRAY) is a Strong Value Stock
Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio Now
Other News for XRAY
Dentsply Sirona Inc. stock rises Friday, still underperforms market
Artisan Global Value Fund Q1 2024 Commentary
Dentsply Sirona Inc. stock underperforms Thursday when compared to competitors
Dentsply Sirona Inc. stock underperforms Wednesday when compared to competitors despite daily gains
Dentsply Sirona: I'm Buying The Pullback In This Medtech Leader